These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 16307208)
1. Optimal design for model discrimination and parameter estimation for itraconazole population pharmacokinetics in cystic fibrosis patients. Waterhouse TH; Redmann S; Duffull SB; Eccleston JA J Pharmacokinet Pharmacodyn; 2005 Aug; 32(3-4):521-45. PubMed ID: 16307208 [TBL] [Abstract][Full Text] [Related]
2. A d-optimal designed population pharmacokinetic study of oral itraconazole in adult cystic fibrosis patients. Hennig S; Waterhouse TH; Bell SC; France M; Wainwright CE; Miller H; Charles BG; Duffull SB Br J Clin Pharmacol; 2007 Apr; 63(4):438-50. PubMed ID: 17073891 [TBL] [Abstract][Full Text] [Related]
3. Population pharmacokinetics of itraconazole and its active metabolite hydroxy-itraconazole in paediatric cystic fibrosis and bone marrow transplant patients. Hennig S; Wainwright CE; Bell SC; Miller H; Friberg LE; Charles BG Clin Pharmacokinet; 2006; 45(11):1099-114. PubMed ID: 17048974 [TBL] [Abstract][Full Text] [Related]
4. Inhalable highly concentrated itraconazole nanosuspension for the treatment of bronchopulmonary aspergillosis. Rundfeldt C; Steckel H; Scherliess H; Wyska E; Wlaź P Eur J Pharm Biopharm; 2013 Jan; 83(1):44-53. PubMed ID: 23064325 [TBL] [Abstract][Full Text] [Related]
5. Itraconazole and allergic bronchopulmonary aspergillosis in twin brothers with cystic fibrosis. Mannes GP; van der Heide S; van Aalderen WM; Gerritsen J Lancet; 1993 Feb; 341(8843):492. PubMed ID: 8094509 [No Abstract] [Full Text] [Related]
17. Population pharmacokinetics of itraconazole solution after a single oral administration in captive lesser flamingos (Phoeniconaias minor). Sánchez CR; Zalesak S; Pich AA; Papich MG J Vet Pharmacol Ther; 2019 Jan; 42(1):1-6. PubMed ID: 30302773 [TBL] [Abstract][Full Text] [Related]
18. A rapid HPLC method with fluorometric detection for determination of plasma itraconazole and hydroxy-itraconazole concentrations in cystic fibrosis children with allergic bronchopulmonary aspergillosis. Redmann S; Charles BG Biomed Chromatogr; 2006 Apr; 20(4):343-8. PubMed ID: 16161186 [TBL] [Abstract][Full Text] [Related]
19. Optimizing the bioavailability of itraconazole. Grant EM Conn Med; 2000 Jul; 64(7):415-7. PubMed ID: 10946480 [No Abstract] [Full Text] [Related]
20. Cushing's syndrome due to pharmacological interaction in a cystic fibrosis patient. Main KM; Skov M; Sillesen IB; Dige-Petersen H; Müller J; Koch C; Lanng S Acta Paediatr; 2002; 91(9):1008-11. PubMed ID: 12412882 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]